Related Experiment Video
Updated: Aug 3, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Parkinson's disease: disability, review, and management
British Medical Journal (Clinical Research Ed.)
|September 13, 1986
Summary
Idiopathic Parkinson's disease significantly impacts community-dwelling patients, with many experiencing moderate to severe symptoms. Regular medical reviews and access to allied health professionals are crucial for improving patient care and support.
Area of Science:
- Neurology
- Public Health
- Gerontology
Background:
- Idiopathic Parkinson's disease (IPD) presents a significant challenge to patients, carers, and healthcare systems.
- Understanding the disease's community impact and available support is crucial for effective management.
Purpose of the Study:
- To describe the impact of idiopathic Parkinson's disease on patients living in the community.
- To assess the level of support and healthcare services available to patients and their carers.
Main Methods:
- Descriptive study analyzing data from 267 idiopathic Parkinson's disease patients (aged 40-92).
- Assessment of disease duration, living situation, medication (levodopa), early retirement, driving cessation, symptom severity, and disability grading (Hoehn and Yahr scale).
- Evaluation of access to regular medical review and allied health professionals (occupational, physiotherapy, speech therapy).
Main Results:
- Median disease duration was 7.2 years; 76.4% lived in the community, 25.1% alone.
- Significant motor and non-motor symptoms were prevalent; 36.4% had Hoehn and Yahr grade 4, 10.7% grade 5 disability.
- Despite symptom severity, 39.6% lacked regular medical review, and access to therapists was low (occupational: 25.1%, physiotherapy: 7.0%, speech therapy: 4.4%).
Conclusions:
- Patients with idiopathic Parkinson's disease experience substantial disability and symptom burden.
- There is a notable gap in regular medical review and access to essential allied health services for many patients.
- Regular medical assessment and multidisciplinary therapy interventions are likely to benefit patients with Parkinson's disease.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...